Unified Agenda

DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary

21 CFR Ch. I

42 CFR Chs. I-V

45 CFR Subtitle A, Chs. II, III, and XIII

Unified Agenda of Federal Regulatory and Deregulatory Actions

AGENCY:

Office of the Secretary, HHS.

ACTION:

Semiannual regulatory agenda.

SUMMARY:

The Regulatory Flexibility Act of 1980 and Executive Order 12866 require the semiannual publication of an agenda outlining all current and projected rulemakings. The purpose of this exercise is to inform the public about regulatory actions under development within the Department, and to provide an opportunity for all concerned with the impact of these regulations to participate in their development at an early stage. The last such agenda was published on November 30, 2000.

FOR FURTHER INFORMATION CONTACT:

Ann Stallion, Department of Health and Human Services, Washington, DC 20201, (202) 690-6824, or the contact person for a specific component of the Department as listed below.

SUPPLEMENTARY INFORMATION:

The regulatory actions capsulized below do not necessarily reflect the new policy perspectives of the Bush administration and HHS Secretary Thompson. The statutorily dictated timing of the regulatory agenda caused the Department to begin its efforts to put together information required for the agenda well before the new Administration came into place. The following agenda thus simply reflects ongoing efforts by HHS to comply with many longstanding statutory obligations, and/or to effect improvements at the program-implementation level based on the Department's experience in administering existing programs. The timing of the October 2001 agenda will, obviously, provide the Department with an opportunity to set out a regulatory agenda that does reflect the policy directions that Secretary Thompson desires to take.

Public commentary is invited. Comments should be sent to the addresses listed below, depending on the specific agenda entry that is of interest. Comments may be sent to the Office of the Secretary if the responsible component of the Department is not apparent, or if a comment covers subjects crossing agency lines.

Administration on Children and Families: Madeline Mocko, Director, Division of Policy and Legislation, 7th Floor, 370 L' Enfant Promenade SW., Washington, DC 20447; Phone 202-401-9223.

Administration on Aging: Harry Posman, Executive Secretariat, Room 4753, 330 Independence Avenue SW., Washington, DC 20201; Phone 202-260-0669.

Agency for Health Care Policy and Research: Nancy Werbel, 2101 East Jefferson Street, Suite 603, Rockville, Maryland 20852; Phone 301-594-1455.

Centers for Disease Control: Thena Durham, Executive Secretariat, 1600 Clifton Road, Building 16, Atlanta, Georgia 30333; Phone 404-639-7120.

Food and Drug Administration: Ed Dutra, Director, Regulatory Policy and Management Staff, 5600 Fishers Lane, Rockville, Maryland 20857; Phone 301-443-3480.

Health Care Financing Administration: Anthony Mazzarella, Deputy Director, Operation Support Group, 7500 Security Boulevard, C4-26-05, Baltimore, Maryland 21244; Phone 410-786-7501.

Health Resource Services Administration: Dolores R. Etherith, 5600 Fishers Lane, Room 14-A-08, Rockville, Maryland 20857; Phone 301-443-1786.

Indian Health Service: Betty Gould, 12300 Twinbrook Parkway, Suite 450, Rockville, Maryland 20857; Phone 301-443-1116.

National Institutes of Health: Jerry Moore, 9000 Rockville Pike, Building 31, Room 1B25, Bethesda, Maryland 20205; Phone 301-496-4606.

Substance Abuse and Mental Health Services Administration: Joe Faha, 5600 Fishers Lane, Room 12-A-17, Rockville, Maryland 20857; Phone 301-443-4640.

Office of the Secretary: Ann C. Agnew, Executive Secretary to the Department, Room 603H, Hubert H. Humphrey Building, 200 Independence Avenue SW., Washington, DC 20201.

Dated:

March 14, 2001.

Ann C. Agnew, Executive Secretary to the Department.

Office of the Secretary—Proposed Rule Stage

Sequence Number Title Regulation Identification Number
813 Governmentwide Debarment and Suspension (Nonprocurement) and Governmentwide Requirements for Drug-Free Workplace (Grants) 0991-AB12

Office of the Secretary—Proposed Rule Stage
Sequence Number	Title	Regulation Identification Number
813	Governmentwide Debarment and Suspension (Nonprocurement) and Governmentwide Requirements for Drug-Free Workplace (Grants)	0991-AB12

Office of the Secretary—Final Rule Stage

Sequence Number Title Regulation Identification Number
814 Reproduction and Sale of Official Forms and Publications 0991-AA83

815 Shared Risk Exception to the Safe Harbor Provisions 0991-AA91

816 Civil Money Penalty Safe Harbor To Protect Payment of Medicare and Medigap Premiums for ESRD Beneficiaries 0991-AB04

817 Safe Harbor for Ambulance Restocking 0991-AB05

818 Revisions and Technical Corrections to 42 CFR Chapter V 0991-AB09

819 Amending the Regulations Governing Nondiscrimination on the Basis of Race, Color, National Origin, Handicap, Sex, and Age To Conform to the Civil Rights Restoration Act of 1987 0991-AB10

Office of the Secretary—Final Rule Stage
Sequence Number	Title	Regulation Identification Number
814	Reproduction and Sale of Official Forms and Publications	0991-AA83
815	Shared Risk Exception to the Safe Harbor Provisions	0991-AA91
816	Civil Money Penalty Safe Harbor To Protect Payment of Medicare and Medigap Premiums for ESRD Beneficiaries	0991-AB04
817	Safe Harbor for Ambulance Restocking	0991-AB05
818	Revisions and Technical Corrections to 42 CFR Chapter V	0991-AB09
819	Amending the Regulations Governing Nondiscrimination on the Basis of Race, Color, National Origin, Handicap, Sex, and Age To Conform to the Civil Rights Restoration Act of 1987	0991-AB10

Office of the Secretary—Long-Term Actions

Sequence Number Title Regulation Identification Number
820 Civil Money Penalties for Medicare+Choice Organizations and Medicaid Managed Care Organizations 0991-AB03

821 Safe Harbor for Arrangements Involving Federally Qualified Health Centers 0991-AB06

822 Definition of Terms; Substantially in Excess and Usual Charges and Clarification of the Good Cause Exception 0991-AB13

Office of the Secretary—Long-Term Actions
Sequence Number	Title	Regulation Identification Number
820	Civil Money Penalties for Medicare+Choice Organizations and Medicaid Managed Care Organizations	0991-AB03
821	Safe Harbor for Arrangements Involving Federally Qualified Health Centers	0991-AB06
822	Definition of Terms; Substantially in Excess and Usual Charges and Clarification of the Good Cause Exception	0991-AB13

Office of the Secretary—Completed Actions

Sequence Number Title Regulation Identification Number
823 Standards for Privacy of Individually Indentifiable Health Information 0991-AB08

Office of the Secretary—Completed Actions
Sequence Number	Title	Regulation Identification Number
823	Standards for Privacy of Individually Indentifiable Health Information	0991-AB08

Substance Abuse and Mental Health Services Administration—Long-Term Actions

Sequence Number Title Regulation Identification Number
824 Substance Abuse Prevention and Treatment Block Grant Applications Due Date Change from March 31 to October 1 for FY 2001 and Beyond 0930-AA04

Substance Abuse and Mental Health Services Administration—Long-Term Actions
Sequence Number	Title	Regulation Identification Number
824	Substance Abuse Prevention and Treatment Block Grant Applications Due Date Change from March 31 to October 1 for FY 2001 and Beyond	0930-AA04

Substance Abuse and Mental Health Services Administration—Completed Actions

Sequence Number Title Regulation Identification Number
825 Final and Delegation of Authority To Implement SAMHSA's Accreditation Based System for Opiod Treatment Program Monitoring 0930-AA06

Substance Abuse and Mental Health Services Administration—Completed Actions
Sequence Number	Title	Regulation Identification Number
825	Final and Delegation of Authority To Implement SAMHSA's Accreditation Based System for Opiod Treatment Program Monitoring	0930-AA06

Centers for Disease Control and Prevention—Proposed Rule Stage

Sequence Number Title Regulation Identification Number
826 Amendments to Quality Assurance and Administrative Provision for Approval of Respiratory Protective Devices 0920-AA04

827 Methods for Estimating Radiation Dose and Guidelines for Assessing Probability of Cancer for Energy Employees Occupational Illness Compensation Program 0920-AA05

Centers for Disease Control and Prevention—Proposed Rule Stage
Sequence Number	Title	Regulation Identification Number
826	Amendments to Quality Assurance and Administrative Provision for Approval of Respiratory Protective Devices	0920-AA04
827	Methods for Estimating Radiation Dose and Guidelines for Assessing Probability of Cancer for Energy Employees Occupational Illness Compensation Program	0920-AA05

Centers for Disease Control and Prevention—Long-Term Actions

Sequence Number Title Regulation Identification Number
828 Packaging and Handling of Infectious Substances and Select Agents 0920-AA02

829 Control of Communicable Diseases 0920-AA03

Centers for Disease Control and Prevention—Long-Term Actions
Sequence Number	Title	Regulation Identification Number
828	Packaging and Handling of Infectious Substances and Select Agents	0920-AA02
829	Control of Communicable Diseases	0920-AA03

Departmental Management—Proposed Rule Stage

Sequence Number Title Regulation Identification Number
830 Implementation of the Equal Access to Justice Act in Agency Proceedings 0990-AA02

Departmental Management—Proposed Rule Stage
Sequence Number	Title	Regulation Identification Number
830	Implementation of the Equal Access to Justice Act in Agency Proceedings	0990-AA02

Food and Drug Administration—Prerule Stage

Sequence Number Title Regulation Identification Number
831 Natural Rubber-Containing Drugs; User Labeling 0910-AB56

832 Implementation of the Import Tolerance Provisions of the Animal Drug Availability Act of 1996 0910-AB71

833 Part 600-Biological Products: General (Section 610 Review) 0910-AC06

Food and Drug Administration—Prerule Stage
Sequence Number	Title	Regulation Identification Number
831	Natural Rubber-Containing Drugs; User Labeling	0910-AB56
832	Implementation of the Import Tolerance Provisions of the Animal Drug Availability Act of 1996	0910-AB71
833	Part 600-Biological Products: General (Section 610 Review)	0910-AC06

Food and Drug Administration—Proposed Rule Stage

Sequence Number Title Regulation Identification Number
834 Over-the-Counter (OTC) Drug Review 0910-AA01

835 Hearing Aids; Professional and Patient Labeling; Conditions for Sale 0910-AA39

836 Establishment Registration and Product Listing for Drugs and Biologics 0910-AA49

837 Investigational New Drugs: Export Requirements for Unapproved New Drug Products 0910-AA61

838 Safety Reporting and Recordkeeping Requirements for Marketed OTC Drugs 0910-AA86

839 Safety Reporting Requirements for Human Drug and Biological Products 0910-AA97

840 Radioactive Drugs for Basic Research 0910-AB00

841 Administrative Practices and Procedures; Advisory Opinions and Guidelines 0910-AB14

842 Current Good Tissue Practice for Manufacturers of Human Cellular and Tissue-Based Products 0910-AB28

843 Applications for FDA Approval to Market a New Drug; Complete Response Letter; Amendments to Unapproved Applications 0910-AB34

844 Expanded Access to Investigational Therapies 0910-AB37

845 Electronic Submission of Adverse Drug Reaction Reports 0910-AB42

846 Distinguishing Marks for Drug Products Containing Insulin 0910-AB43

847 Pregnancy Labeling 0910-AB44

848 Positron Emission Tomography Drugs; Current Good Manufacturing Practices 0910-AB63

849 Current Good Manufacturing Practice for Medicated Feeds 0910-AB70

850 Fixed-Combination Prescription and Over-the-Counter Drugs for Human Use 0910-AB79

851 Repackaging Approval Requirements 0910-AB81

852 Stability Testing of Drugs 0910-AB82

853 Current Good Manufacturing Practice in Manufacturing, Packing, or Holding Dietary Supplements 0910-AB88

854 Submission in Electronic Format of Certain Labeling Information 0910-AB91

855 Fees Relating to Drugs; Waiver and Reduction of Fees 0910-AB92

856 Periodic Testing for Certain Human Drug, Veterinary Drug, and Biological Product Final Specifications 0910-AB93

857 Requirements Pertaining to Sampling Services and Private Laboratories Used in Connection with Imported Food 0910-AB96

858 Medical Devices, Medical Device Establishment Registration and Listing Requirements; Amendment 0910-AB99

859 Availability for Public Disclosure and Submission to FDA for Public Disclosure of Certain Data and Information Related to Gene Therapy or Xenotransplantation 0910-AC00

860 Reporting Information Regarding Potential Fabrication or Falsification of Data 0910-AC02

861 Status Reports for Quantity Marketed Information for Animal Drug Products Used in Food-Producing Animals 0910-AC04

862 Labeling Dietary Supplements for Women Who Are or May Become Pregnant 0910-AC09

863 Overwrap for Inhalation Products Packaged in Low Density Polyethylene (LDPE) Containers 0910-AC10

864 Regulation of Carcinogenic Compounds Used in Food-Producing Animals; Definition of "No Residue" 0910-AC13

865 Control of Salmonella Enteritidis in Shell Eggs During Production and Retail 0910-AC14

866 Aluminum in Large and Small Volume Parenterals Used in Total Parenteral Nutrition 0910-AC18

867 Use of Materials Derived from Ruminant Animals in FDA Regulated Products 0910-AC19

868 Postmarketing Reports of Substandard or Ineffective Bulk Ingredients and Bulk Ingredients from Unapproved Sources 0910-AC20

Food and Drug Administration—Proposed Rule Stage
Sequence Number	Title	Regulation Identification Number
834	Over-the-Counter (OTC) Drug Review	0910-AA01
835	Hearing Aids; Professional and Patient Labeling; Conditions for Sale	0910-AA39
836	Establishment Registration and Product Listing for Drugs and Biologics	0910-AA49
837	Investigational New Drugs: Export Requirements for Unapproved New Drug Products	0910-AA61
838	Safety Reporting and Recordkeeping Requirements for Marketed OTC Drugs	0910-AA86
839	Safety Reporting Requirements for Human Drug and Biological Products	0910-AA97
840	Radioactive Drugs for Basic Research	0910-AB00
841	Administrative Practices and Procedures; Advisory Opinions and Guidelines	0910-AB14
842	Current Good Tissue Practice for Manufacturers of Human Cellular and Tissue-Based Products	0910-AB28
843	Applications for FDA Approval to Market a New Drug; Complete Response Letter; Amendments to Unapproved Applications	0910-AB34
844	Expanded Access to Investigational Therapies	0910-AB37
845	Electronic Submission of Adverse Drug Reaction Reports	0910-AB42
846	Distinguishing Marks for Drug Products Containing Insulin	0910-AB43
847	Pregnancy Labeling	0910-AB44
848	Positron Emission Tomography Drugs; Current Good Manufacturing Practices	0910-AB63
849	Current Good Manufacturing Practice for Medicated Feeds	0910-AB70
850	Fixed-Combination Prescription and Over-the-Counter Drugs for Human Use	0910-AB79
851	Repackaging Approval Requirements	0910-AB81
852	Stability Testing of Drugs	0910-AB82
853	Current Good Manufacturing Practice in Manufacturing, Packing, or Holding Dietary Supplements	0910-AB88
854	Submission in Electronic Format of Certain Labeling Information	0910-AB91
855	Fees Relating to Drugs; Waiver and Reduction of Fees	0910-AB92
856	Periodic Testing for Certain Human Drug, Veterinary Drug, and Biological Product Final Specifications	0910-AB93
857	Requirements Pertaining to Sampling Services and Private Laboratories Used in Connection with Imported Food	0910-AB96
858	Medical Devices, Medical Device Establishment Registration and Listing Requirements; Amendment	0910-AB99
859	Availability for Public Disclosure and Submission to FDA for Public Disclosure of Certain Data and Information Related to Gene Therapy or Xenotransplantation	0910-AC00
860	Reporting Information Regarding Potential Fabrication or Falsification of Data	0910-AC02
861	Status Reports for Quantity Marketed Information for Animal Drug Products Used in Food-Producing Animals	0910-AC04
862	Labeling Dietary Supplements for Women Who Are or May Become Pregnant	0910-AC09
863	Overwrap for Inhalation Products Packaged in Low Density Polyethylene (LDPE) Containers	0910-AC10
864	Regulation of Carcinogenic Compounds Used in Food-Producing Animals; Definition of "No Residue"	0910-AC13
865	Control of Salmonella Enteritidis in Shell Eggs During Production and Retail	0910-AC14
866	Aluminum in Large and Small Volume Parenterals Used in Total Parenteral Nutrition	0910-AC18
867	Use of Materials Derived from Ruminant Animals in FDA Regulated Products	0910-AC19
868	Postmarketing Reports of Substandard or Ineffective Bulk Ingredients and Bulk Ingredients from Unapproved Sources	0910-AC20

Food and Drug Administration—Final Rule Stage

Sequence Number Title Regulation Identification Number
869 New Animal Drug Approval Process; Implementation of Title I of the Generic Animal Drug and Patent Term Restoration Act (GADPTRA) 0910-AA02

870 Current Good Manufacturing Practice; Amendment of Certain Requirements for Finished Pharmaceuticals 0910-AA45

871 Bioavailability and Bioequivalence Requirements 0910-AA51

872 Labeling for Human Prescription Drugs; Revised Format 0910-AA94

873 Current Good Manufacturing Practice; Revision of Certain Labeling Controls 0910-AA98

874 Use of Ozone-Depleting Substances 0910-AA99

875 Exports; Notification and Recordkeeping Requirements 0910-AB16

876 Foreign Establishment Registration and Listing 0910-AB21

877 FDA Export Reform and Enhancement Act of 1996; Reporting and Recordkeeping Requirements for Unapproved or Violative Products Imported for Further Processing or Incorporation and Later Export 0910-AB24

878 Blood Initiative 0910-AB26

879 Antibiotic Drug Approval and Exclusivity 0910-AB33

880 Amendment of Regulations Regarding Certain Label Statements on Prescription Drugs 0910-AB39

881 Supplements and Other Changes to Approved New Animal Drug Applications 0910-AB49

882 Revisions to the General Safety Requirements for Biological Products; Direct Final Rule 0910-AB51

883 Discontinuation of a Lifesaving Product 0910-AB60

884 Supplements and Other Changes to an Approved Application 0910-AB61

885 Food Labeling: Trans Fatty Acids in Nutrition Labeling, Nutrient Content Claims, and Health Claims 0910-AB66

886 Presubmission Conferences 0910-AB68

887 Surgeon's and Patient Examination Gloves; Reclassification 0910-AB74

888 CGMPs for Blood and Blood Components: Notification of Consignees and Transfusion Recipients Receiving Blood and Blood Components at Increased Risk of Transmitting HCV (Lookback) 0910-AB76

889 Antibiotic Resistance Labeling 0910-AB78

890 180-Day Generic Drug Exclusivity for Abbreviated New Drug Applications 0910-AB80

891 Food Additives: Food Contact Substances Notification System 0910-AB94

892 State Certification of Mammography Facilities 0910-AB98

893 Examination of Administrative Record and Other Advisory Committee Records 0910-AC03

894 Efficacy Evidence Needed for Products to be Used Against Toxic Substances When Human Studies Are Unethical 0910-AC05

895 Additional Safeguards for Children in Clinical Investigations of FDA Regulated Products 0910-AC07

896 Implementing Court Decisions, ANDA Approvals, and 180-Day Exclusivity 0910-AC11

897 Revocation of Conditions for Marketing Digoxin Products for Oral Use 0910-AC12

Food and Drug Administration—Final Rule Stage
Sequence Number	Title	Regulation Identification Number
869	New Animal Drug Approval Process; Implementation of Title I of the Generic Animal Drug and Patent Term Restoration Act (GADPTRA)	0910-AA02
870	Current Good Manufacturing Practice; Amendment of Certain Requirements for Finished Pharmaceuticals	0910-AA45
871	Bioavailability and Bioequivalence Requirements	0910-AA51
872	Labeling for Human Prescription Drugs; Revised Format	0910-AA94
873	Current Good Manufacturing Practice; Revision of Certain Labeling Controls	0910-AA98
874	Use of Ozone-Depleting Substances	0910-AA99
875	Exports; Notification and Recordkeeping Requirements	0910-AB16
876	Foreign Establishment Registration and Listing	0910-AB21
877	FDA Export Reform and Enhancement Act of 1996; Reporting and Recordkeeping Requirements for Unapproved or Violative Products Imported for Further Processing or Incorporation and Later Export	0910-AB24
878	Blood Initiative	0910-AB26
879	Antibiotic Drug Approval and Exclusivity	0910-AB33
880	Amendment of Regulations Regarding Certain Label Statements on Prescription Drugs	0910-AB39
881	Supplements and Other Changes to Approved New Animal Drug Applications	0910-AB49
882	Revisions to the General Safety Requirements for Biological Products; Direct Final Rule	0910-AB51
883	Discontinuation of a Lifesaving Product	0910-AB60
884	Supplements and Other Changes to an Approved Application	0910-AB61
885	Food Labeling: Trans Fatty Acids in Nutrition Labeling, Nutrient Content Claims, and Health Claims	0910-AB66
886	Presubmission Conferences	0910-AB68
887	Surgeon's and Patient Examination Gloves; Reclassification	0910-AB74
888	CGMPs for Blood and Blood Components: Notification of Consignees and Transfusion Recipients Receiving Blood and Blood Components at Increased Risk of Transmitting HCV (Lookback)	0910-AB76
889	Antibiotic Resistance Labeling	0910-AB78
890	180-Day Generic Drug Exclusivity for Abbreviated New Drug Applications	0910-AB80
891	Food Additives: Food Contact Substances Notification System	0910-AB94
892	State Certification of Mammography Facilities	0910-AB98
893	Examination of Administrative Record and Other Advisory Committee Records	0910-AC03
894	Efficacy Evidence Needed for Products to be Used Against Toxic Substances When Human Studies Are Unethical	0910-AC05
895	Additional Safeguards for Children in Clinical Investigations of FDA Regulated Products	0910-AC07
896	Implementing Court Decisions, ANDA Approvals, and 180-Day Exclusivity	0910-AC11
897	Revocation of Conditions for Marketing Digoxin Products for Oral Use	0910-AC12

Food and Drug Administration—Long-Term Actions

Sequence Number Title Regulation Identification Number
898 Infant Formula: Good Manufacturing Practice, Quality Control Procedures, Quality Factors, Notification Requirements, and Records and Reports 0910-AA04

899 Food Labeling Review 0910-AA19

900 Medical Foods 0910-AA20

901 Classification of Computer Software Programs That Are Medical Devices 0910-AA41

902 Reinventing FDA Food Regulations 0910-AA58

903 Determination That Informed Consent Is Infeasible or Is Contrary to the Best Interest of Recipients 0910-AA89

904 Direct-to-Consumer Promotion Regulations 0910-AA90

905 Investigational Use New Animal Drug Regulations (Section 610 Review) 0910-AB02

906 Suitability Determination for Donors of Human Cellular and Tissue-Based Products 0910-AB27

907 Requirements for Liquid Medicated Feed and Free-Choice Medicated Feed 0910-AB50

908 Bulk Drug Substances for Use in Pharmacy Compounding 0910-AB57

909 Pharmacy and Physician Compounding of Drug Products 0910-AB58

910 Drug Products That Present Demonstrable Difficulties for Compounding Because of Reasons of Safety or Effectiveness 0910-AB59

911 Mandatory HACCP Regulations for Manufacturers of Rendered Products 0910-AB72

912 Citizen Petitions; Actions That Can Be Requested by Petition; Denials, Withdrawals, and Referrals for Other Administrative Action 0910-AB73

913 Substances Prohibited From Use in Animal Food or Feed 0910-AB90

914 Marking Requirements for and Prohibitions on the Reimportation of Imported Food Products That Have Been Refused Admission into the United States 0910-AB95

915 Addition to the List of Drug Products That Have Been Withdrawn From the Market for Reasons of Safety or Effectiveness 0910-AC01

916 Addition to the List of Drug Products That Have Been Withdrawn or Removed From the Market for Reasons of Safety or Effectiveness 0910-AC08

917 Premarket Notice Concerning Bioengineered Foods 0910-AC15

918 Rescission of Substantially Equivalent Decisions and Rescission Appeal Procedures 0910-AC16

919 Institutional Review Boards: Registration Requirements 0910-AC17

920 Chronic Wasting Disease: Control of Food Products and Cosmetics Derived from Exposed Animal Populations 0910-AC21

Food and Drug Administration—Long-Term Actions
Sequence Number	Title	Regulation Identification Number
898	Infant Formula: Good Manufacturing Practice, Quality Control Procedures, Quality Factors, Notification Requirements, and Records and Reports	0910-AA04
899	Food Labeling Review	0910-AA19
900	Medical Foods	0910-AA20
901	Classification of Computer Software Programs That Are Medical Devices	0910-AA41
902	Reinventing FDA Food Regulations	0910-AA58
903	Determination That Informed Consent Is Infeasible or Is Contrary to the Best Interest of Recipients	0910-AA89
904	Direct-to-Consumer Promotion Regulations	0910-AA90
905	Investigational Use New Animal Drug Regulations (Section 610 Review)	0910-AB02
906	Suitability Determination for Donors of Human Cellular and Tissue-Based Products	0910-AB27
907	Requirements for Liquid Medicated Feed and Free-Choice Medicated Feed	0910-AB50
908	Bulk Drug Substances for Use in Pharmacy Compounding	0910-AB57
909	Pharmacy and Physician Compounding of Drug Products	0910-AB58
910	Drug Products That Present Demonstrable Difficulties for Compounding Because of Reasons of Safety or Effectiveness	0910-AB59
911	Mandatory HACCP Regulations for Manufacturers of Rendered Products	0910-AB72
912	Citizen Petitions; Actions That Can Be Requested by Petition; Denials, Withdrawals, and Referrals for Other Administrative Action	0910-AB73
913	Substances Prohibited From Use in Animal Food or Feed	0910-AB90
914	Marking Requirements for and Prohibitions on the Reimportation of Imported Food Products That Have Been Refused Admission into the United States	0910-AB95
915	Addition to the List of Drug Products That Have Been Withdrawn From the Market for Reasons of Safety or Effectiveness	0910-AC01
916	Addition to the List of Drug Products That Have Been Withdrawn or Removed From the Market for Reasons of Safety or Effectiveness	0910-AC08
917	Premarket Notice Concerning Bioengineered Foods	0910-AC15
918	Rescission of Substantially Equivalent Decisions and Rescission Appeal Procedures	0910-AC16
919	Institutional Review Boards: Registration Requirements	0910-AC17
920	Chronic Wasting Disease: Control of Food Products and Cosmetics Derived from Exposed Animal Populations	0910-AC21

Food and Drug Administration—Completed Actions

Sequence Number Title Regulation Identification Number
921 Biological Products: Reporting of Biological Product Deviations in Manufacturing 0910-AA12

922 Fruit and Vegetable Juices: Development of HACCP and Label Warning Statements for Juices 0910-AA43

923 Drugs Used for Treatment of Narcotic Addicts 0910-AA52

924 Establishment Registration and Listing of Human Cells, Tissues, and Cellular and Tissue-Based Products 0910-AB05

925 Veterinary Feed Directives 0910-AB09

926 Shell Eggs: Warning, Notice and Safe Handling Labeling Statements and Refrigeration Requirements 0910-AB30

927 Postmarketing Studies for Human Drugs and Licensed Biological Products: Status Reports 0910-AB83

928 Current Good Manufacturing Practice for Blood and Blood Components; Blood Labeling Standards 0910-AB89

Food and Drug Administration—Completed Actions
Sequence Number	Title	Regulation Identification Number
921	Biological Products: Reporting of Biological Product Deviations in Manufacturing	0910-AA12
922	Fruit and Vegetable Juices: Development of HACCP and Label Warning Statements for Juices	0910-AA43
923	Drugs Used for Treatment of Narcotic Addicts	0910-AA52
924	Establishment Registration and Listing of Human Cells, Tissues, and Cellular and Tissue-Based Products	0910-AB05
925	Veterinary Feed Directives	0910-AB09
926	Shell Eggs: Warning, Notice and Safe Handling Labeling Statements and Refrigeration Requirements	0910-AB30
927	Postmarketing Studies for Human Drugs and Licensed Biological Products: Status Reports	0910-AB83
928	Current Good Manufacturing Practice for Blood and Blood Components; Blood Labeling Standards	0910-AB89

Health Resources and Services Administration—Proposed Rule Stage

Sequence Number Title Regulation Identification Number
929 Designation of Medically Underserved Populations and Health Professional Shortage Areas 0906-AA44

930 National Vaccine Injury Compensation Program: Revisions and Additions to the Vaccine Injury Table 0906-AA55

Health Resources and Services Administration—Proposed Rule Stage
Sequence Number	Title	Regulation Identification Number
929	Designation of Medically Underserved Populations and Health Professional Shortage Areas	0906-AA44
930	National Vaccine Injury Compensation Program: Revisions and Additions to the Vaccine Injury Table	0906-AA55

Health Resources and Services Administration—Final Rule Stage

Sequence Number Title Regulation Identification Number
931 National Practitioner Data Bank for Adverse Information on Physicians and Other Health Care Practitioners: Medical Malpractice Payments Reporting Requirements 0906-AA41

932 Compliance Alternatives for Provision of Uncompensated Services 0906-AA52

933 Final Rule for the Health Professions, Nursing, Public Health, and Allied Health Training Grant Programs Under 42 CFR Parts 57 and 58 0906-AA53

Health Resources and Services Administration—Final Rule Stage
Sequence Number	Title	Regulation Identification Number
931	National Practitioner Data Bank for Adverse Information on Physicians and Other Health Care Practitioners: Medical Malpractice Payments Reporting Requirements	0906-AA41
932	Compliance Alternatives for Provision of Uncompensated Services	0906-AA52
933	Final Rule for the Health Professions, Nursing, Public Health, and Allied Health Training Grant Programs Under 42 CFR Parts 57 and 58	0906-AA53

Health Resources and Services Administration—Completed Actions

Sequence Number Title Regulation Identification Number
934 Ricky Ray Hemophilia Relief Fund Program 0906-AA56

Health Resources and Services Administration—Completed Actions
Sequence Number	Title	Regulation Identification Number
934	Ricky Ray Hemophilia Relief Fund Program	0906-AA56

Indian Health Service—Proposed Rule Stage

Sequence Number Title Regulation Identification Number
935 Tribal Self-Governance Amendments 0917-AA05

Indian Health Service—Proposed Rule Stage
Sequence Number	Title	Regulation Identification Number
935	Tribal Self-Governance Amendments	0917-AA05

Indian Health Service—Final Rule Stage

Sequence Number Title Regulation Identification Number
936 Indian Child Protection and Family Violence Prevention Act Minimum Standards of Character 0917-AA02

Indian Health Service—Final Rule Stage
Sequence Number	Title	Regulation Identification Number
936	Indian Child Protection and Family Violence Prevention Act Minimum Standards of Character	0917-AA02

Indian Health Service—Completed Actions

Sequence Number Title Regulation Identification Number
937 Contracts Under the Indian Self-Determination Act 0917-AA04

Indian Health Service—Completed Actions
Sequence Number	Title	Regulation Identification Number
937	Contracts Under the Indian Self-Determination Act	0917-AA04

National Institutes of Health—Proposed Rule Stage

Sequence Number Title Regulation Identification Number
938 National Institutes of Health AIDS Research Loan Repayment Program 0925-AA02

939 Undergraduate Scholarship Program Regarding Professions Needed by the NIH 0925-AA10

940 National Cancer Institute Clinical Cancer Education Program 0925-AA17

941 National Institutes of Health Loan Repayment Program for Research 0925-AA18

942 NIH Center Grants 0925-AA24

943 National Institutes of Health Clinics Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds 0925-AA25

944 NIH Loan Repayment Program for Minority Health Disparties Research 0925-AA26

945 Pediatric Research Loan Repayment Program 0925-AA27

946 NIH Training Grants 0925-AA28

National Institutes of Health—Proposed Rule Stage
Sequence Number	Title	Regulation Identification Number
938	National Institutes of Health AIDS Research Loan Repayment Program	0925-AA02
939	Undergraduate Scholarship Program Regarding Professions Needed by the NIH	0925-AA10
940	National Cancer Institute Clinical Cancer Education Program	0925-AA17
941	National Institutes of Health Loan Repayment Program for Research	0925-AA18
942	NIH Center Grants	0925-AA24
943	National Institutes of Health Clinics Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds	0925-AA25
944	NIH Loan Repayment Program for Minority Health Disparties Research	0925-AA26
945	Pediatric Research Loan Repayment Program	0925-AA27
946	NIH Training Grants	0925-AA28

National Institutes of Health—Final Rule Stage

Sequence Number Title Regulation Identification Number
947 National Research Service Awards 0925-AA16

948 National Institute of Child Health and Human Development Contraception and Infertility Research Loan Repayment Program 0925-AA19

949 Scientific Peer Review of Research Grant Applications and Research and Development Contract Projects 0925-AA20

National Institutes of Health—Final Rule Stage
Sequence Number	Title	Regulation Identification Number
947	National Research Service Awards	0925-AA16
948	National Institute of Child Health and Human Development Contraception and Infertility Research Loan Repayment Program	0925-AA19
949	Scientific Peer Review of Research Grant Applications and Research and Development Contract Projects	0925-AA20

National Institutes of Health—Completed Actions

Sequence Number Title Regulation Identification Number
950 Traineeships 0925-AA11

951 Additional Protections for Pregnant Women and Human Fetuses Involved in Research, and Pertaining to Human In Vitro Fertilization 0925-AA14

952 Federal Policy (Common Rule) for the Protection of Human Subjects 0925-AA21

National Institutes of Health—Completed Actions
Sequence Number	Title	Regulation Identification Number
950	Traineeships	0925-AA11
951	Additional Protections for Pregnant Women and Human Fetuses Involved in Research, and Pertaining to Human In Vitro Fertilization	0925-AA14
952	Federal Policy (Common Rule) for the Protection of Human Subjects	0925-AA21

Office of Public Health and Science—Final Rule Stage

Sequence Number Title Regulation Identification Number
953 Public Health Service Standards for the Protection of Research Misconduct Whistleblowers 0940-AA01

954 Federal Policy (Common Rule) for the Protection of Human Subjects 0940-AA03

Office of Public Health and Science—Final Rule Stage
Sequence Number	Title	Regulation Identification Number
953	Public Health Service Standards for the Protection of Research Misconduct Whistleblowers	0940-AA01
954	Federal Policy (Common Rule) for the Protection of Human Subjects	0940-AA03

Office of Public Health and Science—Completed Actions

Sequence Number Title Regulation Identification Number
955 Additional Protections for Pregnant Women and Human Fetuses Involved in Research, and Pertaining to Human In Vitro Fertilization 0940-AA02

Office of Public Health and Science—Completed Actions
Sequence Number	Title	Regulation Identification Number
955	Additional Protections for Pregnant Women and Human Fetuses Involved in Research, and Pertaining to Human In Vitro Fertilization	0940-AA02

Health Care Financing Administration—Proposed Rule Stage

Sequence Number Title Regulation Identification Number
956 End Stage Renal Disease (ESRD) Conditions for Coverage (HCFA-3818-P) (Section 610 Review) 0938-AG82

957 Recognition of the American Osteopathic Association for Critical Access Hospitals (HCFA-2099-PN) 0938-AK84

Health Care Financing Administration—Proposed Rule Stage
Sequence Number	Title	Regulation Identification Number
956	End Stage Renal Disease (ESRD) Conditions for Coverage (HCFA-3818-P) (Section 610 Review)	0938-AG82
957	Recognition of the American Osteopathic Association for Critical Access Hospitals (HCFA-2099-PN)	0938-AK84

Health Care Financing Administration—Final Rule Stage

Sequence Number Title Regulation Identification Number
958 Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities-Update (HCFA-1163-P) 0938-AK47

Health Care Financing Administration—Final Rule Stage
Sequence Number	Title	Regulation Identification Number
958	Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities-Update (HCFA-1163-P)	0938-AK47

Health Care Financing Administration—Long-Term Actions

Sequence Number Title Regulation Identification Number
959 "Without Fault" and Beneficiary Waiver of Recovery As It Applies to Medicare Overpayment Liability (HCFA-6007-F) 0938-AD95

960 Medicaid Payment for Covered Outpatient Drugs Under Rebate Agreements (HCFA-2046-FC) 0938-AF42

961 Revision of Medicare/Medicaid Hospital Conditions of Participation (HCFA-3745-F) 0938-AG79

962 Home Health Agency (HHA) Conditions of Participation (HCFA-3819-F) 0938-AG81

963 Liability for Third Parties To Pay for Services (HCFA-2080-P) 0938-AH01

964 Criteria for Approval of Facilities to Perform Covered Heart, Liver, Lung, Pancreas and Intestinal Transplants (HCFA-3835-P) 0938-AH17

965 Hospice Care-Conditions of Participation (HCFA-3844-P) 0938-AH27

966 Requirements for Enrollment of Medicaid Recipients Under Cost Effective Employer-Based Group Health Plans (HCFA-2047-F) 0938-AH48

967 Terms, Definitions, and Addresses: Technical Amendments (HCFA-9877-FC) 0938-AH53

968 Requirements for Establishing and Maintaining Medicare Billing Privileges (HCFA-6002-P) 0938-AH73

969 Update of Ratesetting Methodology, Payment Rates and the List of Covered Surgical Procedures for Ambulatory Surgical Centers (HCFA-1885-FC) 0938-AH81

970 Revisions to Conditions for Coverage for Ambulatory Surgical Centers (HCFA-3887-P) 0938-AH83

971 National Standard for Identifiers of Health Plans (HCFA-4145-P) 0938-AH87

972 Standard Unique Health Care Provider Identifier (HCFA-0045-F) 0938-AH99

973 Medicaid: Medical Child Support (HCFA-2081-P) 0938-AI21

974 Surety Bond Requirements for Comprehensive Outpatient Rehabilitation Facilities, Rehabilitation Agencies (HCFA-6005-P) 0938-AI48

975 Appeals of Carrier Determination That a Physician or Other Supplier Fails To Meet the Requirements for Medicare Billing Privileges (HCFA-6003-F) 0938-AI49

976 Security Standards (HCFA-0049-F) 0938-AI57

977 National Standard Employer Identifier (HCFA-0047-F) 0938-AI59

978 Medicare Program; Advance Refunding of Debt and Methodology for Repayment of Loan (HCFA-1777-P) 0938-AI75

979 Medicare Program; Medicare Coverage of and Payment for Bone Mass Measurements (HCFA-3004-F) 0938-AI89

980 Medicare Program; Coverage and Administrative Policies for Clinical Diagnostic Laboratory Tests (HCFA-3250-F) 0938-AI92

981 Coverage of Religious Non-Medical Health Care Institutions (HCFA-1909-F) 0938-AI93

982 External Quality Review of Medicaid Managed Care Organizations (HCFA-2015-F) 0938-AJ06

983 Reporting Outcome and Assessment Information Set (OASIS) Data as Part of the Conditions of Participation for Home Health Agencies (HCFA-3006-F) 0938-AJ10

984 Rural Health Clinics: Amendments to Participation Requirements and Payment Provisions, and Establishment of a Quality Assessment and Improvement Program (HCFA-1910-F) 0938-AJ17

985 Hospital Conditions of Participation: Laboratory Services (HCFA-3014-F) 0938-AJ29

986 Medicare Hospice Care Amendments (HCFA-1022-P) 0938-AJ36

987 Emergency Medical Treatment and Labor Act (EMTALA) (HCFA-1063-P) 0938-AJ39

988 Protection for Women Who Elect Reconstruction After a Mastectomy (HCFA-2040-IFC) 0938-AJ44

989 Medicare Program: Prospective Payment System for Inpatient Rehabilitation Hospital Services (HCFA-1069-F) 0938-AJ55

990 DME Surety Bonds (HCFA-6006-P) 0938-AJ64

991 State Health Insurance Assistance Program (SHIP) (HCFA-4005-F) 0938-AJ67

992 HHA Surety Bond (HCFA-6001-P) 0938-AJ81

993 Application of Inherent Reasonableness to All Part B Services Other Than Physician Services (HCFA-1908-F) 0938-AJ97

994 Supplier Standards Related to Training Requirements for Oxygen, Therapeutic Shoes (HCFA-6010-NPRM) 0938-AJ98

995 Non-Federal Governmental Plans Exempt From HIPAA (HCFA-2033-IFC) 0938-AK00

996 End Stage Renal Disease Bad Debt Payment (HCFA-1126-P) 0938-AK02

997 Practice Expense Data Collection (HCFA-1111-IFC) 0938-AK14

998 Payment for Clinical Psychology Training Programs (HCFA-1089-F) 0938-AK15

999 Provisions of the Balanced Budget and Refinement Act of 1999; Hospital Inpatient Payments and Rates and Costs of Graduate Medical Education (HCFA-1131-IFC) 0938-AK20

1000 Conditions of Participation of Intermediate Care Facilities for Persons With Mental Retardation (HCFA-3046-P) 0938-AK23

1001 Clinical Lab Requirements-Revisions to Regulations Implementing CLIA (HCFA-2226-F) 0938-AK24

1002 Prospective Fee Schedule for Ambulance Services (HCFA-1002-F) 0938-AK30

1003 Fire Safety Requirements for RNHCI, ASC, Hospices, PACE, Hospitals, and Long-Term Care Facilities (HCFA-3047-P) 0938-AK35

1004 Medicare Provider and Supplier Hearing Procedures (HCFA-2093-P) 0938-AK39

1005 Hospital Conditions of Participation: Quality Assessment and Performance Improvements (HCFA-3050-F) 0938-AK40

1006 Requirements for the Recredentialing of Medicare+Choice Organizations Providers (HCFA-1160-F) 0938-AK41

1007 Supplementary Medical Insurance Premium Surcharge Agreements (HCFA-4007-P) 0938-AK42

1008 Medical Devices Coverage Decisions Related to Health Care Technology (HCFA-3059-P) 0938-AK43

1009 Medicaid Management Information System Revised Definition of "Mechanized Claims Processing and Information Retrieval System" (HCFA-2123-IFC) 0938-AK44

1010 Medicare Program; Reporting and Repayment of Overpayments (HCFA-6011-P) 0938-AK45

1011 Improvements to the Medicare+Choice Appeals and Grievance Procedures (HCFA-4024-F) 0938-AK48

1012 Civil Money Penalties, Assessments, and Revised Sanction Authorities (HCFA-6145-FC) 0938-AK49

1013 Payment for Upgraded Durable Medical Equipment (HCFA-1084-F) 0938-AK50

1014 Update to the Prospective Payment System for Home Health Agencies for FY 2002 (HCFA-1147-NC) 0938-AK51

1015 Recognition of the American Osteopathic Association for Ambulatory Surgical Center Programs (HCFA-2079-FN) 0938-AK53

1016 Prospective Payment System for Hospital Outpatient Services (HCFA-1159-P) 0938-AK54

1017 Medicare as Secondary Payer-Recovery of Conditional Payments (HCFA-6009-P) 0938-AK55

1018 Five Year Review of Work Relative Value Units Under the Physician Fee Schedule Proposed Notice (HCFA-1170-PN) 0938-AK56

1019 Revisions to Payment Policies Under the Physician Fee Schedule for Calendar Year 2002 (HCFA-1169-P) 0938-AK57

1020 Changes to National Coverage Determinations and Local Coverage Determinations (HCFA-4019-FC) 0938-AK58

1021 Revisions to the Prospective Payment System for Hospital Outpatient Services Mandated by BIPA (HCFA-1179-IFC) 0938-AK59

1022 Challenges to National Coverage Determinations and Local Coverage Determinations (HCFA-3063-P) 0938-AK60

1023 Revised Process for Making Medicare Coverage Decisions (HCFA-3062-N) 0938-AK61

1024 Claims Attachment Standard (HCFA-0050-P) 0938-AK62

1025 Standards for Electronic Signatures (HCFA-0051-F) 0938-AK63

1026 Health Insurance Reform: Modifications to Standards for Electronic Transaction (HCFA-0003-IFC) 0938-AK64

1027 Replacement of Reasonable Charge Methodology by Fee Schedule (HCFA-1010-F) 0938-AK66

1028 Physicians' Referrals to Health Care Entities With Which They Have Financial Relationships-Phase II (HCFA-1810-FC) 0938-AK67

1029 Increase in the Rate of Reimbursement of Photocopy Expenses for Prospective Payment System Providers (HCFA-3055-P) 0938-AK68

1030 Long Term Care Prospective Payment System for FY 2003 (HCFA-1177-P) 0938-AK69

1031 Modifications to Managed Care Rules Based on Provisions of BIPA and Technical Corrections (HCFA-1180-P) 0938-AK71

1032 Changes to the Hospital Inpatients Prospective Payment System for Fiscal Year 2002 Rates (HCFA-1158-P) 0938-AK73

1033 Changes to Inpatient BIPA for Fiscal Year 2001 (HCFA-1178-IFC) 0938-AK74

1034 Medicare+Choice ESRD Rates (HCFA-1182-PN) 0938-AK75

1035 Revisions to Transaction and Code Set Standards for Electronic Transactions (HCFA-0005-IFC) 0938-AK76

1036 Medicare Inpatient Disproportionate Share Hospital Adjustment Calculation (HCFA-1171-IFC) 0938-AK77

1037 Statement of Intent (HCFA-1185-P) 0938-AK79

1038 Procedures for Public Consultations for Coding and Payment Determinations for New Laboratory Tests (HCFA-1186-N) 0938-AK80

1039 Organ Procurement Organization Condition for Coverage (HCFA-3064-P) 0938-AK81

1040 Qualification Requirements for Directors of Laboratories Performing High Complexity Testing (HCFA-2094-NPRM) 0938-AK83

1041 Protection and Promotion of Resident Rights (HCFA-3065-P) 0938-AK85

1042 Standards for Electronic Transactions-Elimination of NDC Coding Standards (HCFA-0006-P) 0938-AK86

1043 Hospital Reference Laboratory and Medicare Secondary Payer (HCFA-1187-P) 0938-AK87

1044 Portability in the Group Health Insurance Market (HCFA-2048-F) 0938-AK88

Health Care Financing Administration—Long-Term Actions
Sequence Number	Title	Regulation Identification Number
959	"Without Fault" and Beneficiary Waiver of Recovery As It Applies to Medicare Overpayment Liability (HCFA-6007-F)	0938-AD95
960	Medicaid Payment for Covered Outpatient Drugs Under Rebate Agreements (HCFA-2046-FC)	0938-AF42
961	Revision of Medicare/Medicaid Hospital Conditions of Participation (HCFA-3745-F)	0938-AG79
962	Home Health Agency (HHA) Conditions of Participation (HCFA-3819-F)	0938-AG81
963	Liability for Third Parties To Pay for Services (HCFA-2080-P)	0938-AH01
964	Criteria for Approval of Facilities to Perform Covered Heart, Liver, Lung, Pancreas and Intestinal Transplants (HCFA-3835-P)	0938-AH17
965	Hospice Care-Conditions of Participation (HCFA-3844-P)	0938-AH27
966	Requirements for Enrollment of Medicaid Recipients Under Cost Effective Employer-Based Group Health Plans (HCFA-2047-F)	0938-AH48
967	Terms, Definitions, and Addresses: Technical Amendments (HCFA-9877-FC)	0938-AH53
968	Requirements for Establishing and Maintaining Medicare Billing Privileges (HCFA-6002-P)	0938-AH73
969	Update of Ratesetting Methodology, Payment Rates and the List of Covered Surgical Procedures for Ambulatory Surgical Centers (HCFA-1885-FC)	0938-AH81
970	Revisions to Conditions for Coverage for Ambulatory Surgical Centers (HCFA-3887-P)	0938-AH83
971	National Standard for Identifiers of Health Plans (HCFA-4145-P)	0938-AH87
972	Standard Unique Health Care Provider Identifier (HCFA-0045-F)	0938-AH99
973	Medicaid: Medical Child Support (HCFA-2081-P)	0938-AI21
974	Surety Bond Requirements for Comprehensive Outpatient Rehabilitation Facilities, Rehabilitation Agencies (HCFA-6005-P)	0938-AI48
975	Appeals of Carrier Determination That a Physician or Other Supplier Fails To Meet the Requirements for Medicare Billing Privileges (HCFA-6003-F)	0938-AI49
976	Security Standards (HCFA-0049-F)	0938-AI57
977	National Standard Employer Identifier (HCFA-0047-F)	0938-AI59
978	Medicare Program; Advance Refunding of Debt and Methodology for Repayment of Loan (HCFA-1777-P)	0938-AI75
979	Medicare Program; Medicare Coverage of and Payment for Bone Mass Measurements (HCFA-3004-F)	0938-AI89
980	Medicare Program; Coverage and Administrative Policies for Clinical Diagnostic Laboratory Tests (HCFA-3250-F)	0938-AI92
981	Coverage of Religious Non-Medical Health Care Institutions (HCFA-1909-F)	0938-AI93
982	External Quality Review of Medicaid Managed Care Organizations (HCFA-2015-F)	0938-AJ06
983	Reporting Outcome and Assessment Information Set (OASIS) Data as Part of the Conditions of Participation for Home Health Agencies (HCFA-3006-F)	0938-AJ10
984	Rural Health Clinics: Amendments to Participation Requirements and Payment Provisions, and Establishment of a Quality Assessment and Improvement Program (HCFA-1910-F)	0938-AJ17
985	Hospital Conditions of Participation: Laboratory Services (HCFA-3014-F)	0938-AJ29
986	Medicare Hospice Care Amendments (HCFA-1022-P)	0938-AJ36
987	Emergency Medical Treatment and Labor Act (EMTALA) (HCFA-1063-P)	0938-AJ39
988	Protection for Women Who Elect Reconstruction After a Mastectomy (HCFA-2040-IFC)	0938-AJ44
989	Medicare Program: Prospective Payment System for Inpatient Rehabilitation Hospital Services (HCFA-1069-F)	0938-AJ55
990	DME Surety Bonds (HCFA-6006-P)	0938-AJ64
991	State Health Insurance Assistance Program (SHIP) (HCFA-4005-F)	0938-AJ67
992	HHA Surety Bond (HCFA-6001-P)	0938-AJ81
993	Application of Inherent Reasonableness to All Part B Services Other Than Physician Services (HCFA-1908-F)	0938-AJ97
994	Supplier Standards Related to Training Requirements for Oxygen, Therapeutic Shoes (HCFA-6010-NPRM)	0938-AJ98
995	Non-Federal Governmental Plans Exempt From HIPAA (HCFA-2033-IFC)	0938-AK00
996	End Stage Renal Disease Bad Debt Payment (HCFA-1126-P)	0938-AK02
997	Practice Expense Data Collection (HCFA-1111-IFC)	0938-AK14
998	Payment for Clinical Psychology Training Programs (HCFA-1089-F)	0938-AK15
999	Provisions of the Balanced Budget and Refinement Act of 1999; Hospital Inpatient Payments and Rates and Costs of Graduate Medical Education (HCFA-1131-IFC)	0938-AK20
1000	Conditions of Participation of Intermediate Care Facilities for Persons With Mental Retardation (HCFA-3046-P)	0938-AK23
1001	Clinical Lab Requirements-Revisions to Regulations Implementing CLIA (HCFA-2226-F)	0938-AK24
1002	Prospective Fee Schedule for Ambulance Services (HCFA-1002-F)	0938-AK30
1003	Fire Safety Requirements for RNHCI, ASC, Hospices, PACE, Hospitals, and Long-Term Care Facilities (HCFA-3047-P)	0938-AK35
1004	Medicare Provider and Supplier Hearing Procedures (HCFA-2093-P)	0938-AK39
1005	Hospital Conditions of Participation: Quality Assessment and Performance Improvements (HCFA-3050-F)	0938-AK40
1006	Requirements for the Recredentialing of Medicare+Choice Organizations Providers (HCFA-1160-F)	0938-AK41
1007	Supplementary Medical Insurance Premium Surcharge Agreements (HCFA-4007-P)	0938-AK42
1008	Medical Devices Coverage Decisions Related to Health Care Technology (HCFA-3059-P)	0938-AK43
1009	Medicaid Management Information System Revised Definition of "Mechanized Claims Processing and Information Retrieval System" (HCFA-2123-IFC)	0938-AK44
1010	Medicare Program; Reporting and Repayment of Overpayments (HCFA-6011-P)	0938-AK45
1011	Improvements to the Medicare+Choice Appeals and Grievance Procedures (HCFA-4024-F)	0938-AK48
1012	Civil Money Penalties, Assessments, and Revised Sanction Authorities (HCFA-6145-FC)	0938-AK49
1013	Payment for Upgraded Durable Medical Equipment (HCFA-1084-F)	0938-AK50
1014	Update to the Prospective Payment System for Home Health Agencies for FY 2002 (HCFA-1147-NC)	0938-AK51
1015	Recognition of the American Osteopathic Association for Ambulatory Surgical Center Programs (HCFA-2079-FN)	0938-AK53
1016	Prospective Payment System for Hospital Outpatient Services (HCFA-1159-P)	0938-AK54
1017	Medicare as Secondary Payer-Recovery of Conditional Payments (HCFA-6009-P)	0938-AK55
1018	Five Year Review of Work Relative Value Units Under the Physician Fee Schedule Proposed Notice (HCFA-1170-PN)	0938-AK56
1019	Revisions to Payment Policies Under the Physician Fee Schedule for Calendar Year 2002 (HCFA-1169-P)	0938-AK57
1020	Changes to National Coverage Determinations and Local Coverage Determinations (HCFA-4019-FC)	0938-AK58
1021	Revisions to the Prospective Payment System for Hospital Outpatient Services Mandated by BIPA (HCFA-1179-IFC)	0938-AK59
1022	Challenges to National Coverage Determinations and Local Coverage Determinations (HCFA-3063-P)	0938-AK60
1023	Revised Process for Making Medicare Coverage Decisions (HCFA-3062-N)	0938-AK61
1024	Claims Attachment Standard (HCFA-0050-P)	0938-AK62
1025	Standards for Electronic Signatures (HCFA-0051-F)	0938-AK63
1026	Health Insurance Reform: Modifications to Standards for Electronic Transaction (HCFA-0003-IFC)	0938-AK64
1027	Replacement of Reasonable Charge Methodology by Fee Schedule (HCFA-1010-F)	0938-AK66
1028	Physicians' Referrals to Health Care Entities With Which They Have Financial Relationships-Phase II (HCFA-1810-FC)	0938-AK67
1029	Increase in the Rate of Reimbursement of Photocopy Expenses for Prospective Payment System Providers (HCFA-3055-P)	0938-AK68
1030	Long Term Care Prospective Payment System for FY 2003 (HCFA-1177-P)	0938-AK69
1031	Modifications to Managed Care Rules Based on Provisions of BIPA and Technical Corrections (HCFA-1180-P)	0938-AK71
1032	Changes to the Hospital Inpatients Prospective Payment System for Fiscal Year 2002 Rates (HCFA-1158-P)	0938-AK73
1033	Changes to Inpatient BIPA for Fiscal Year 2001 (HCFA-1178-IFC)	0938-AK74
1034	Medicare+Choice ESRD Rates (HCFA-1182-PN)	0938-AK75
1035	Revisions to Transaction and Code Set Standards for Electronic Transactions (HCFA-0005-IFC)	0938-AK76
1036	Medicare Inpatient Disproportionate Share Hospital Adjustment Calculation (HCFA-1171-IFC)	0938-AK77
1037	Statement of Intent (HCFA-1185-P)	0938-AK79
1038	Procedures for Public Consultations for Coding and Payment Determinations for New Laboratory Tests (HCFA-1186-N)	0938-AK80
1039	Organ Procurement Organization Condition for Coverage (HCFA-3064-P)	0938-AK81
1040	Qualification Requirements for Directors of Laboratories Performing High Complexity Testing (HCFA-2094-NPRM)	0938-AK83
1041	Protection and Promotion of Resident Rights (HCFA-3065-P)	0938-AK85
1042	Standards for Electronic Transactions-Elimination of NDC Coding Standards (HCFA-0006-P)	0938-AK86
1043	Hospital Reference Laboratory and Medicare Secondary Payer (HCFA-1187-P)	0938-AK87
1044	Portability in the Group Health Insurance Market (HCFA-2048-F)	0938-AK88

Health Care Financing Administration—Completed Actions

Sequence Number Title Regulation Identification Number
1045 Changes to Peer Review Organization Regulations (HCFA-3135-F) 0938-AD38

1046 Protection of Income and Resources for Community Spouses of Institutionalized Individuals (HCFA-2023-P) 0938-AE12

1047 Early and Periodic Screening, Diagnostic, and Treatment (EPSDT) Services (HCFA-2028-F) 0938-AE72

1048 Payment for Nursing and Allied Health Science Education (HCFA-1685-F) 0938-AE79

1049 Coverage of Screening Pap Smears (HCFA-3705-F) 0938-AE98

1050 Referral to Child Support Enforcement Agencies of Medicaid Families (HCFA-2051-F) 0938-AF68

1051 Disclosure of Confidential PRO and ESRD Network Organization Information for Research Purposes (HCFA-3208-P) 0938-AG33

1052 Effect of Change of Ownership on Provider and Supplier Penalties, Sanctions, Underpayments and Overpayments (HCFA-2215-P) 0938-AG59

1053 Optional Coverage of Certain Tuberculosis to TB-Related Services, TB-Infected Individuals (HCFA-2082-P) 0938-AG72

1054 Physicians' Referrals to Health Care Entities With Which They Have Financial Relationships-Expanded to Designated Health Services (HCFA-1809-FC) 0938-AG80

1055 Distinct Part Requirements for Nursing Homes and Prohibition on Financial Screening of Applicants for Nursing Home Admission (HCFA-3815-P) 0938-AG84

1056 CLIA Program: Categorization of Waived Tests (HCFA-2225-FC) 0938-AG99

1057 Additional Supplier Standards (HCFA-6004-FC) 0938-AH19

1058 State Plan Amendment (SPA) Reconsideration Process (HCFA-2096-P) 0938-AH24

1059 Medicare Coverage of Services of Speech-Language Pathologists and Audiologists (HCFA-1843-P) 0938-AH37

1060 Medicaid; Estate Recoveries (HCFA-2083-P) 0938-AH63

1061 Individual Market Health Insurance Reform: Portability From Group to Individual Coverage; Federal Rules for Access in the Individual Market; State Alternative Mechanisms to Federal Rules (HCFA-2882-F) 0938-AH75

1062 Disclosure of Peer Review Organization Information in Response to Beneficiary Complaints (HCFA-3241-P) 0938-AH85

1063 Medicaid Program; Amendment to the Preadmission Screening and Annual Resident Review Program (HCFA-2107-P) 0938-AH89

1064 Medically Needy Determinations Under Welfare Reform (HCFA-2109-IFC) 0938-AH92

1065 Medicaid Program; Coverage and Payment for Federally Qualified Health Center Services (HCFA-2043-P) 0938-AH95

1066 Nondiscrimination in Health Coverage in the Group Market (HCFA-2022-F) 0938-AI08

1067 Medicare Program; Improvements to the Appeals Process for Medicare Beneficiaries Enrolled in HMOs, CMPs, and HCPPs (HCFA-4024-P) 0938-AI11

1068 Medicare Program; Adjustments to Cost Limits for Skilled Nursing Facility Inpatient Routine Service Costs (HCFA-1896-FN) 0938-AI14

1069 Medicare/Medicaid Program; User Fees for Information, Products, and Services (HCFA-6021-P) 0938-AI46

1070 Prospective Payment System for Hospital Outpatient Services (HCFA-1005-F) 0938-AI56

1071 State Plan Requirements for Durable Medical Equipment Providers (HCFA-2007-P) 0938-AI63

1072 Medicaid Program; Home and Community-Based Services (HCFA-2010-FC) 0938-AI67

1073 Medicaid Managed Care; Regulatory Program To Implement Certain Medicaid Provisions of the Balanced Budget Act of 1997 (HCFA-2001-F) 0938-AI70

1074 Prospective Fee Schedule for Ambulance Services (HCFA-1002-P) 0938-AI72

1075 Revision of Procedures for Requesting Exceptions to Cost Limits for SNFs and Elimination of Reclassifications (HCFA-1883-F) 0938-AI80

1076 Expanded Coverage for Diabetes Outpatient Self-Management Training Services (HCFA-3002-F) 0938-AI96

1077 Medicare Program; Criteria and Standards for Evaluating Intermediary and Carrier Performance: Millennium Compliance (HCFA-4002-GNC) 0938-AJ15

1078 Medicare/Medicaid and CLIA Programs: Clinical Laboratory Improvement Amendments of 1988 Exemption of Laboratories in the State of California (HCFA-2245-N) 0938-AJ47

1079 Medicare Program: Criteria for Making National Coverage Decision (HCFA-3432-P) 0938-AJ54

1080 Medicare Program; Sustainable Growth Rate for Fiscal Year 2000 (HCFA-1110-N) 0938-AJ60

1081 Medicare and Medicaid Programs; Programs for All-Inclusive Care for the Elderly (PACE) (HCFA-1903-P) 0938-AJ63

1082 Clinical Social Worker Services (HCFA-1088-F) 0938-AJ71

1083 Medicaid Disproportionate Share Hospital Payments-Institutions for Mental Disease (HCFA-2062-N) 0938-AJ74

1084 The Children's Health Insurance Program: Implementing the Balanced Budget Act of 1997 (HCFA-2006-F) 0938-AJ75

1085 Medicare Program Update of Ambulatory Surgical Center Payment Rates Effective for Services On or After October 1, 1999 (HCFA-1085-N) 0938-AJ86

1086 Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities-Update (HCFA-1112-F) 0938-AJ93

1087 Use of Restraint and Seclusion in Residential Treatment Facilities Providing Inpatient Psychiatric Services to Individuals Under Age 21 (HCFA-2065-F) 0938-AJ96

1088 Conditions of Participation for Intermediate Care Facilities for the Mentally Retarded 0938-AJ99

1089 Flexibility in Payment Methods for Services of Hospitals, Nursing Facilities, and Intermediate Care Facilities for the Mentally Retarded (HCFA-2004-F) 0938-AK04

1090 Hospital Conditions of Participation; Anesthesia Services (HCFA-3049-F) 0938-AK08

1091 Changes to the Appeals Process for Beneficiaries Receiving Home Health Services in the Fee For Service Program (HCFA-4006-P) 0938-AK10

1092 Revisions to Payment Policies Under the Physician Fee Schedule for Calendar Year 2001 (HCFA-1120-F) 0938-AK11

1093 Revisions to Medicaid Upper Payment Limit Requirements for Hospital, Nursing Facility, Intermediate Care Facility Services for the Mentally Retarded and Clinic Services (HCFA-2071-F) 0938-AK12

1094 Hospice Wage Index (HCFA-1135-N) 0938-AK13

1095 HIPAA Program; Bona Fide Wellness Programs (HCFA-2078-F) 0938-AK19

1096 Application of Federal Financial Participation Limits (HCFA-2086-F) 0938-AK22

1097 Prospective Payment System for Hospital Outpatient Services: Exception to the Provider-Based Location Criteria for PPS-Exempt Facilities (HCFA-1143-F) 0938-AK25

1098 Criteria and Standards for Evaluating Intermediary and Carrier Performance During FY 2001 (HCFA-4010-GNC) 0938-AK26

1099 Inpatient Hospital Deductible and Hospital and Extended Care Services Coinsurance Amounts for Calendar Year 2001 (HCFA-8007-N) 0938-AK27

1100 Mandatory Transmission of OASIS for Non-Medicare/Medicaid Patients in Home Health Agencies and Continued Delay of Requirements for Patients Receiving Personal Care Services (HCFA-2070-N) 0938-AK28

1101 Removal of the Requirements for the Cardiac Pacemaker Registry (HCFA-3045-F) 0938-AK29

1102 Physicians' Referrals to Health Care Entities With Which They Have Financial Relationships-Phase II (HCFA-1810-FC) 0938-AK31

1103 Elimination of Application of Federal Financial Participation Limits (HCFA-2086-P) 0938-AK32

1104 Conforming Regulations Changes and Statutory Revisions for Approval and Oversight of Accreditation Organizations (HCFA-2088-P) 0938-AK36

Health Care Financing Administration—Completed Actions
Sequence Number	Title	Regulation Identification Number
1045	Changes to Peer Review Organization Regulations (HCFA-3135-F)	0938-AD38
1046	Protection of Income and Resources for Community Spouses of Institutionalized Individuals (HCFA-2023-P)	0938-AE12
1047	Early and Periodic Screening, Diagnostic, and Treatment (EPSDT) Services (HCFA-2028-F)	0938-AE72
1048	Payment for Nursing and Allied Health Science Education (HCFA-1685-F)	0938-AE79
1049	Coverage of Screening Pap Smears (HCFA-3705-F)	0938-AE98
1050	Referral to Child Support Enforcement Agencies of Medicaid Families (HCFA-2051-F)	0938-AF68
1051	Disclosure of Confidential PRO and ESRD Network Organization Information for Research Purposes (HCFA-3208-P)	0938-AG33
1052	Effect of Change of Ownership on Provider and Supplier Penalties, Sanctions, Underpayments and Overpayments (HCFA-2215-P)	0938-AG59
1053	Optional Coverage of Certain Tuberculosis to TB-Related Services, TB-Infected Individuals (HCFA-2082-P)	0938-AG72
1054	Physicians' Referrals to Health Care Entities With Which They Have Financial Relationships-Expanded to Designated Health Services (HCFA-1809-FC)	0938-AG80
1055	Distinct Part Requirements for Nursing Homes and Prohibition on Financial Screening of Applicants for Nursing Home Admission (HCFA-3815-P)	0938-AG84
1056	CLIA Program: Categorization of Waived Tests (HCFA-2225-FC)	0938-AG99
1057	Additional Supplier Standards (HCFA-6004-FC)	0938-AH19
1058	State Plan Amendment (SPA) Reconsideration Process (HCFA-2096-P)	0938-AH24
1059	Medicare Coverage of Services of Speech-Language Pathologists and Audiologists (HCFA-1843-P)	0938-AH37
1060	Medicaid; Estate Recoveries (HCFA-2083-P)	0938-AH63
1061	Individual Market Health Insurance Reform: Portability From Group to Individual Coverage; Federal Rules for Access in the Individual Market; State Alternative Mechanisms to Federal Rules (HCFA-2882-F)	0938-AH75
1062	Disclosure of Peer Review Organization Information in Response to Beneficiary Complaints (HCFA-3241-P)	0938-AH85
1063	Medicaid Program; Amendment to the Preadmission Screening and Annual Resident Review Program (HCFA-2107-P)	0938-AH89
1064	Medically Needy Determinations Under Welfare Reform (HCFA-2109-IFC)	0938-AH92
1065	Medicaid Program; Coverage and Payment for Federally Qualified Health Center Services (HCFA-2043-P)	0938-AH95
1066	Nondiscrimination in Health Coverage in the Group Market (HCFA-2022-F)	0938-AI08
1067	Medicare Program; Improvements to the Appeals Process for Medicare Beneficiaries Enrolled in HMOs, CMPs, and HCPPs (HCFA-4024-P)	0938-AI11
1068	Medicare Program; Adjustments to Cost Limits for Skilled Nursing Facility Inpatient Routine Service Costs (HCFA-1896-FN)	0938-AI14
1069	Medicare/Medicaid Program; User Fees for Information, Products, and Services (HCFA-6021-P)	0938-AI46
1070	Prospective Payment System for Hospital Outpatient Services (HCFA-1005-F)	0938-AI56
1071	State Plan Requirements for Durable Medical Equipment Providers (HCFA-2007-P)	0938-AI63
1072	Medicaid Program; Home and Community-Based Services (HCFA-2010-FC)	0938-AI67
1073	Medicaid Managed Care; Regulatory Program To Implement Certain Medicaid Provisions of the Balanced Budget Act of 1997 (HCFA-2001-F)	0938-AI70
1074	Prospective Fee Schedule for Ambulance Services (HCFA-1002-P)	0938-AI72
1075	Revision of Procedures for Requesting Exceptions to Cost Limits for SNFs and Elimination of Reclassifications (HCFA-1883-F)	0938-AI80
1076	Expanded Coverage for Diabetes Outpatient Self-Management Training Services (HCFA-3002-F)	0938-AI96
1077	Medicare Program; Criteria and Standards for Evaluating Intermediary and Carrier Performance: Millennium Compliance (HCFA-4002-GNC)	0938-AJ15
1078	Medicare/Medicaid and CLIA Programs: Clinical Laboratory Improvement Amendments of 1988 Exemption of Laboratories in the State of California (HCFA-2245-N)	0938-AJ47
1079	Medicare Program: Criteria for Making National Coverage Decision (HCFA-3432-P)	0938-AJ54
1080	Medicare Program; Sustainable Growth Rate for Fiscal Year 2000 (HCFA-1110-N)	0938-AJ60
1081	Medicare and Medicaid Programs; Programs for All-Inclusive Care for the Elderly (PACE) (HCFA-1903-P)	0938-AJ63
1082	Clinical Social Worker Services (HCFA-1088-F)	0938-AJ71
1083	Medicaid Disproportionate Share Hospital Payments-Institutions for Mental Disease (HCFA-2062-N)	0938-AJ74
1084	The Children's Health Insurance Program: Implementing the Balanced Budget Act of 1997 (HCFA-2006-F)	0938-AJ75
1085	Medicare Program Update of Ambulatory Surgical Center Payment Rates Effective for Services On or After October 1, 1999 (HCFA-1085-N)	0938-AJ86
1086	Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities-Update (HCFA-1112-F)	0938-AJ93
1087	Use of Restraint and Seclusion in Residential Treatment Facilities Providing Inpatient Psychiatric Services to Individuals Under Age 21 (HCFA-2065-F)	0938-AJ96
1088	Conditions of Participation for Intermediate Care Facilities for the Mentally Retarded	0938-AJ99
1089	Flexibility in Payment Methods for Services of Hospitals, Nursing Facilities, and Intermediate Care Facilities for the Mentally Retarded (HCFA-2004-F)	0938-AK04
1090	Hospital Conditions of Participation; Anesthesia Services (HCFA-3049-F)	0938-AK08
1091	Changes to the Appeals Process for Beneficiaries Receiving Home Health Services in the Fee For Service Program (HCFA-4006-P)	0938-AK10
1092	Revisions to Payment Policies Under the Physician Fee Schedule for Calendar Year 2001 (HCFA-1120-F)	0938-AK11
1093	Revisions to Medicaid Upper Payment Limit Requirements for Hospital, Nursing Facility, Intermediate Care Facility Services for the Mentally Retarded and Clinic Services (HCFA-2071-F)	0938-AK12
1094	Hospice Wage Index (HCFA-1135-N)	0938-AK13
1095	HIPAA Program; Bona Fide Wellness Programs (HCFA-2078-F)	0938-AK19
1096	Application of Federal Financial Participation Limits (HCFA-2086-F)	0938-AK22
1097	Prospective Payment System for Hospital Outpatient Services: Exception to the Provider-Based Location Criteria for PPS-Exempt Facilities (HCFA-1143-F)	0938-AK25
1098	Criteria and Standards for Evaluating Intermediary and Carrier Performance During FY 2001 (HCFA-4010-GNC)	0938-AK26
1099	Inpatient Hospital Deductible and Hospital and Extended Care Services Coinsurance Amounts for Calendar Year 2001 (HCFA-8007-N)	0938-AK27
1100	Mandatory Transmission of OASIS for Non-Medicare/Medicaid Patients in Home Health Agencies and Continued Delay of Requirements for Patients Receiving Personal Care Services (HCFA-2070-N)	0938-AK28
1101	Removal of the Requirements for the Cardiac Pacemaker Registry (HCFA-3045-F)	0938-AK29
1102	Physicians' Referrals to Health Care Entities With Which They Have Financial Relationships-Phase II (HCFA-1810-FC)	0938-AK31
1103	Elimination of Application of Federal Financial Participation Limits (HCFA-2086-P)	0938-AK32
1104	Conforming Regulations Changes and Statutory Revisions for Approval and Oversight of Accreditation Organizations (HCFA-2088-P)	0938-AK36

Administration for Children and Families—Proposed Rule Stage

Sequence Number Title Regulation Identification Number
1105 Program Performance Standards for the Operation of Head Start Programs 0970-AB99

1106 Safeguarding Child Support and Expanded FPLS Information 0970-AC01

1107 Developmental Disabilities and Bill of Rights Act 0970-AC07

Administration for Children and Families—Proposed Rule Stage
Sequence Number	Title	Regulation Identification Number
1105	Program Performance Standards for the Operation of Head Start Programs	0970-AB99
1106	Safeguarding Child Support and Expanded FPLS Information	0970-AC01
1107	Developmental Disabilities and Bill of Rights Act	0970-AC07

Administration for Children and Families—Final Rule Stage

Sequence Number Title Regulation Identification Number
1108 Construction and Major Renovation of Head Start and Early Head Start Facilities 0970-AB54

1109 Child Support Enforcement for Indian Tribes 0970-AB73

1110 Child Support Enforcement Program Omnibus Conforming Regulation 0970-AB81

1111 Family Child Care Program Option for Head Start Programs 0970-AB90

1112 Technical Revision of Head Start Regulations To Make Them Conform to Recent Statutory Revisions 0970-AC00

1113 High Performance Bonus Awards Under the TANF Program 0970-AC06

1114 Individual Development Accounts 0970-AC08

Administration for Children and Families—Final Rule Stage
Sequence Number	Title	Regulation Identification Number
1108	Construction and Major Renovation of Head Start and Early Head Start Facilities	0970-AB54
1109	Child Support Enforcement for Indian Tribes	0970-AB73
1110	Child Support Enforcement Program Omnibus Conforming Regulation	0970-AB81
1111	Family Child Care Program Option for Head Start Programs	0970-AB90
1112	Technical Revision of Head Start Regulations To Make Them Conform to Recent Statutory Revisions	0970-AC00
1113	High Performance Bonus Awards Under the TANF Program	0970-AC06
1114	Individual Development Accounts	0970-AC08

Administration for Children and Families—Completed Actions

Sequence Number Title Regulation Identification Number
1115 Standards for Safe Transportation 0970-AB24

1116 Incentive Payments and Audit Penalties to States and Political Subdivisions 0970-AB85

1117 State Self-Assessments To Determine Compliance With Federal Regulations 0970-AB96

1118 National Medical Support Notice 0970-AB97

Administration for Children and Families—Completed Actions
Sequence Number	Title	Regulation Identification Number
1115	Standards for Safe Transportation	0970-AB24
1116	Incentive Payments and Audit Penalties to States and Political Subdivisions	0970-AB85
1117	State Self-Assessments To Determine Compliance With Federal Regulations	0970-AB96
1118	National Medical Support Notice	0970-AB97

Administration on Aging—Proposed Rule Stage

Sequence Number Title Regulation Identification Number
1119 Grants for State and Community Programs on Aging, Intrastate Funding Formulas; Training, Research and Discretionary Programs; Vulnerable Elder Rights; and Grants to Indians and Native Hawaiians 0985-AA00

1120 Grants for State and Community Programs on Aging, Family Caregivers, American Indians, and Native Hawaiians (Section 610 Review) 0985-AA01